NASDAQ:APRE

Aprea Therapeutics Stock Forecast

etoro logo Buy APRE
*Your capital is at risk
$0.745
+0.0170 (+2.34%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of APRE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add APRE to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Aprea Therapeutics Inc. stock price ended at $0.745 on Friday, after gaining 2.34%
(Updated on Jul 10, 2026)

Sell candidate since Jun 30, 2026 Loss -7.14%

The Aprea Therapeutics Inc. stock price gained 2.34% on the last trading day (Friday, 10th Jul 2026), rising from $0.728 to $0.745. During the last trading day the stock fluctuated 3.97% from a day low at $0.745 to a day high of $0.775. The price has been going up and down for this period, and there has been a -5.68% loss for the last 2 weeks. Volume fell on the last day by -29 thousand shares and in total, 14 thousand shares were bought and sold for approximately $10.80 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.03% during the next 3 months and, with a 90% probability hold a price between $0.508 and $0.685 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

APRE Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 09, 2026, and so far it has risen 2.34%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aprea Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.746 and $0.793. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Tuesday, May 19, 2026 and based on theory for this formation the price should go up by 51.95% to $1.13 within 13 trading days (Monday, June 08, 2026) since signal was issued.

Support, Risk & Stop-loss for Aprea Therapeutics Inc. stock

Aprea Therapeutics Inc. finds support from accumulated volume at $0.741 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0296 between high and low, or 3.97%. For the last week the stock has had daily average volatility of 4.82%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (APRE) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Aprea Therapeutics Inc. to open at $0.755, and during the day (based on 14 day Average True Range), to move between $0.716 and $0.774, which gives a possible trading interval of +/-$0.0586 (+/-8.19%) up or down from last closing price. If Aprea Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 8.19% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.741 (0.48%) than the resistance at $0.794 (6.52%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aprea Therapeutics Inc. stock A Buy?

Aprea Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.112 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $0.755 ( 1.32%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

APRE Performance

Trading levels for APRE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.784 5.30%
R2 0.773 3.78%
R1 0.766 2.84%
Price 0.745
S1 0.744 -0.193%
S2 0.737 -1.13%
S3 0.725 -2.65%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.91 21.79%
R2 0.88 18.21%
R1 0.794 6.52%
Price 0.745
S1 0.741 -0.483%
S2 0.741 -0.537%
S3 0.686 -7.91%

FAQ

What is the symbol for Aprea Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Aprea Therapeutics Inc. is APRE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aprea Therapeutics Inc. Stock?
Aprea Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Aprea Therapeutics Inc. Stock?
Aprea Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aprea Therapeutics Inc. Stock.

What's the current price of Aprea Therapeutics Inc. Stock?
As of the end of day on the Jul 10, 2026, the price of an Aprea Therapeutics Inc. (APRE) share was $0.745.

What is the 52-week high and low for Aprea Therapeutics Inc. Stock?
The 52-week high for Aprea Therapeutics Inc. Stock is $2.22 and the 52-week low is $0.548.

What is the market capitalization of Aprea Therapeutics Inc. Stock?
As of the Jul 10, 2026, the market capitalization of Aprea Therapeutics Inc. is 4.838M.

When is the next earnings date for Aprea Therapeutics Inc.?
The upcoming earnings date for Aprea Therapeutics Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT APREA THERAPEUTICS INC.
Aprea Therapeutics
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATR...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE